Wed, 21 Feb 2018 14:59:41 +0000 By LINDA TEMBO THE National Biosafety Authority has approved two applications for HIV vaccine trials and Malaria Control to be conducted at the Centre for Infectious Disease Research in Zambia (CIDRZ) and Macha Research Trust respectively. Speaking during a two day workshop aimed at enhancing effectiveness of the National Biosafety Clearing House, NBA Chairperson Paul Zambezi said the CIDRZ permitted the conducting of the research trials on the safety and immunogenicity of vaccine. He said the trials will be conducted in Lusaka while the malaria control will be done at Macha Research Trust Southern Province. Dr Zambezi explained that the National Biosafety Clearing House was set up to promote and facilitate technical and scientific cooperation. He said NBA was a statutory body established under the Biosafety Act no. 10 of 2007. “Our mandate is to regulate the research development, application, import, export, transit, contained use, release or placing on […]
